• Mandana Moradi, Mojtaba Mojtahedzadeh, Ali Mandegari, Mohammad Sadegh Soltan-Sharifi, Atabak Najafi, Mohammad Reza Khajavi, Molook Hajibabayee, and Mohammad Hossein Ghahremani.
• Department of Clinical Pharmacy, Tehran University of Medical Sciences, Iran.
• Respir Med. 2009 Mar 1;103(3):434-41.

AbstractOxidative stress has a proven role in pathophysiology of acute respiratory distress syndrome. The antioxidant drugs, especially N-acetylcysteine (NAC) have been used for years to overcome oxidative stress effects in patients. In the present study we have investigated the effects of NAC treatment (IV NAC in 150mg/kg at the first day followed by 50mg/kg/day for three days) on 27 ICU patients with ALI/ARDS considering the glutathione-S-transferase genetic variations, as an important enzyme contributing in oxidative stress pathways. The results indicated that NAC improved oxygenation (increase in PaO(2)/FiO(2)) and decreased mortality rate in treated patients compared to control group (p<0.05). Evaluation of three isoforms of glutathione-S-transferase (GST M1, P1 and T1), in these patients have showed an association between GST M1 null, and GST M1 and T1 double null polymorphisms with increased mortality in control group, suggesting antioxidant therapy critical for this group of patients.

32 keywords...

hide…